Chundsell Medicals Company
Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. The Prostatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
Last Funding Type:
Private Equity
Headquarters:
Kista, Stockholms Lan, Sweden
Founded Date:
2007-01-01
Investor Type:
For Profit
Technology:
P4 Medicine
Estimated Revenue:
$1M to $10M
Investors Number:
1
Industry:
Biotechnology, Health Care, Science and Engineering